Healthcare Sector

MRK

Market Tracker

$80.50
-0.46
(-0.57%)
5:40 am
Next Earnings: (est.) 08/01/23 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/18/2025 CALL $80.00 1,680 +1,680
07/18/2025 PUT $80.00 1,680 +1,680
06/27/2025 CALL $84.00 2,420 +1,300 +116.07%
06/27/2025 PUT $78.00 1,582 +1,258 +388.27%
09/19/2025 PUT $80.00 6,763 +979 +16.93%
01/16/2026 CALL $110.00 4,598 +921 +25.05%
12/19/2025 PUT $115.00 606 -517 -46.04%
07/18/2025 PUT $95.00 2,722 -527 -16.22%
06/20/2025 PUT $90.00 5,745 -774 -11.87%
12/19/2025 PUT $120.00 35 -828 -95.94%
06/20/2025 PUT $105.00 326 -1,330 -80.31%
06/20/2025 PUT $95.00 3,708 -2,404 -39.33%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 77.07M 8.28B
Vanguard 500 Index Fund 2.31% 58.61M 6.3B
Fidelity 500 Index Fund 1.09% 27.79M 2.99B
SPDR S&P 500 ETF Trust 1.08% 27.45M 2.95B
iShares Core S&P 500 ETF 0.89% 22.63M 2.43B
Vanguard Index-Value Index Fund 0.86% 21.91M 2.35B
Select Sector SPDR Fund-Health Care 0.81% 20.59M 2.21B
Vanguard Specialized-Health Care Fund 0.72% 18.31M 1.97B
Vanguard Institutional Index Fund-Institutional Index Fund 0.70% 17.77M 1.91B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.68% 17.38M 1.87B

MRK News

  • These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in May 2025

    06/14 08:02 am

    The Motley Fool

    Read more
  • Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery

    06/13 02:08 pm

    Benzinga

    Read more
  • Why Summit Therapeutics Stock Tanked Today

    06/11 05:28 pm

    The Motley Fool

    Read more
  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    05/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • MRK Down 21% YTD: Should You Buy, Hold or Sell the Stock?

    05/26 11:01 am

    Zacks Investment Research

    Read more
  • 3 Deep-Value Stocks to Buy as Bulls Take a Breather

    05/22 10:16 am

    Investing.com

    Read more
  • Moderna Stock Looks Ripe for a Short Squeeze

    05/22 08:21 am

    Investing.com

    Read more
  • Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

    05/22 08:00 am

    GlobeNewswire Inc.

    Read more
  • Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption

    05/19 10:56 am

    GlobeNewswire Inc.

    Read more
  • Neurofibromatosis Type 1 Market Set to Witness Significant Growth During the Study Period (2020–2034) Driven by Advances in Treatment | DelveInsight

    05/15 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows

    05/14 11:31 am

    The Motley Fool

    Read more
  • TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing

    05/13 03:00 am

    GlobeNewswire Inc.

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Beaten-Down Stocks That Are Great Buys on the Dip

    05/08 09:12 am

    The Motley Fool

    Read more
  • Can Summit Therapeutics Stock Double Your Money?

    05/07 09:30 am

    The Motley Fool

    Read more
  • Multiple System Atrophy (MSA) Market Research 2025-2035 - Emerging Alpha-Synuclein Therapies and Strategic Pharma Collaborations Propel MSA Market Towards Disease-Modifying Breakthroughs

    05/07 04:41 am

    GlobeNewswire Inc.

    Read more
  • Liver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®

    05/02 10:00 am

    GlobeNewswire Inc.

    Read more
  • This Soaring Stock Just Delivered More Good News. Time to Buy?

    05/02 08:30 am

    The Motley Fool

    Read more
  • Should Investors Buy Merck Stock After These Huge Risks?

    04/30 11:30 am

    The Motley Fool

    Read more
  • Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

    04/30 04:56 am

    GlobeNewswire Inc.

    Read more
  • Why Is Summit Therapeutics Stock Trading Higher On Monday?

    04/28 01:00 pm

    Benzinga

    Read more
  • Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

    04/28 12:17 pm

    Benzinga

    Read more
  • 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

    04/28 08:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

    04/26 02:32 pm

    The Motley Fool

    Read more
  • What's Going On With Summit Therapeutics Stock On Friday?

    04/25 03:14 pm

    Benzinga

    Read more
  • Durable Goods Orders Jump 9.2% In March, But One Category Tells The Real Story

    04/24 09:20 am

    Benzinga

    Read more
  • Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

    04/21 02:49 pm

    Benzinga

    Read more
  • Meningococcal Vaccines Market Size to Surpass $9.05 Billion, Globally, by 2032 at 10.4% CAGR: Coherent Market Insights

    04/21 11:00 am

    GlobeNewswire Inc.

    Read more
  • המועד האחרון לתביעה נגד MRK ביום שני: רוזן, מבכירי היועצים הגלובליים, מעודד את משקיעי Merck & Co., Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 14 באפריל בתביעה ייצוגית בניירות ערך – MRK

    04/12 11:11 am

    GlobeNewswire Inc.

    Read more
  • MRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK

    04/12 11:11 am

    GlobeNewswire Inc.

    Read more
  • Why This Chinese Biotech Could Be Pharma's DeepSeek

    04/11 10:18 am

    Benzinga

    Read more
  • Alarum Technologies Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. April 15, 2025 Deadline to file Lead Plaintiff Motion.

    04/10 06:53 pm

    GlobeNewswire Inc.

    Read more
  • Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion

    04/10 06:46 pm

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

    04/10 05:59 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, GLOBAL INVESTOR COUNSEL, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EU

    04/09 05:36 pm

    GlobeNewswire Inc.

    Read more
  • Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

    04/09 03:15 am

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

    04/06 10:05 am

    GlobeNewswire Inc.

    Read more
  • MRK DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK

    04/05 08:17 am

    GlobeNewswire Inc.

    Read more
  • BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit

    04/03 11:19 am

    Benzinga

    Read more
  • Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

    03/31 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Pfizer Is My Largest Healthcare Position

    03/27 06:45 am

    The Motley Fool

    Read more
  • Why Summit Therapeutics Stock Slipped Today

    03/26 05:21 pm

    The Motley Fool

    Read more
  • DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    03/26 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Pharma and Biotech Stocks Got Thrashed on Tuesday

    03/25 06:47 pm

    The Motley Fool

    Read more
  • Analyst Initiates Coverage On 'Undervalued' Summit Therapeutics

    03/24 02:17 pm

    Benzinga

    Read more
  • SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

    03/23 08:46 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: